#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15494	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2066	742.0	0	.	n	.	0	C451T	SNP	451	451	C	634	634	T	848	T,C	432,355	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15494	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2066	742.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1367	1367	C	961	C	888	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15494	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2066	742.0	0	HET	.	.	.	C227T,G	.	227	227	C	410	410	C	876	C,T,G	408,404,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15494	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2066	742.0	0	HET	.	.	.	C207T	.	207	207	C	390	390	C	888	C,T	626,184	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27840	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3461	800.8	0	.	n	.	0	T695C	SNP	695	695	T	1020	1020	C	876	C	812	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27840	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3461	800.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1963	1963	G	894	G,A	630,199	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27840	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3461	800.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2296	2296	C	916	C	849	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27840	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3461	800.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2370	2370	A	883	A,C	821,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27840	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3461	800.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2922	2922	C	864	C	802	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2160	folP	855	855	100.0	folP.l6.c30.ctg.1	1516	141.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1031	1033	AGC	229;229;230	A;G;C	212;214;213	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6180	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3550	173.8	1	SNP	p	S91F	1	.	.	271	273	TTC	667	669	TTC	222;220;221	T;T;C	209;207;208	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6180	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3550	173.8	1	SNP	p	G95N	0	.	.	283	285	GGC	679	681	GGC	219;217;215	G;G;C	203;201;201	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6180	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3550	173.8	1	SNP	p	D95G	1	.	.	283	285	GGC	679	681	GGC	219;217;215	G;G;C	203;201;201	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1682	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1342	124.8	1	SNP	p	G45D	0	.	.	133	135	GGC	499	501	GGC	220;219;218	G;G;C	209;208;205	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	850	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1017	83.4	0	.	n	.	0	A197.	DEL	197	197	A	573	573	A	182	A	163	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5958	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2865	207.1	1	SNP	p	D86N	0	.	.	256	258	GAC	525	527	GAC	241;244;244	G;A;C	226;223;230	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5958	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2865	207.1	1	SNP	p	R87I	0	.	.	259	261	CGT	528	530	CGT	247;245;245	C;G;T	233;230;231	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5958	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2865	207.1	1	SNP	p	S87R	1	.	.	259	261	CGT	528	530	CGT	247;245;245	C;G;T	233;230;231	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5958	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2865	207.1	1	SNP	p	R87W	0	.	.	259	261	CGT	528	530	CGT	247;245;245	C;G;T	233;230;231	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5958	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2865	207.1	1	SNP	p	S88P	0	.	.	262	264	TCC	531	533	TCC	246;249;249	T;C;C	225;236;235	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4588	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2610	175.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1510	1512	GGC	226;226;227	G;G;C	212;205;208	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2185	185.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1150	1152	GCC	213;210;211	GCC,GC;C;C	200,1;196;195	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2185	185.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1153	1155	ATG	211;214;213	A;T;G	196;199;198	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2185	185.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1165	1167	ACC	212;211;211	A;C;C	196;194;194	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2185	185.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1165	1167	ACC	212;211;211	A;C;C	196;194;194	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2185	185.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1666	1668	ACC	197;198;200	A;C;C	179;183;186	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2185	185.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1720	1722	GCG	214;213;214	G;C,A;G	195;196,1;198	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2185	185.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1720	1722	GCG	214;213;214	G;C,A;G	195;196,1;198	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2185	185.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1843	1845	GGT	179;179;179	G;G;T	167;166;164	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2185	185.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1852	1854	AGC	175;176;171	A;G;C	158;161;153	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4084	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2185	185.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1870	1872	CCG	159;163;161	C,G,T;C;G	116,9,1;123;117	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6062	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	2883	208.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1554	1556	CCG	216;218;217	C;C,T;G	186;196,1;191	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2588	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1608	159.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	468	468	C	205	C	190	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	A251V	NONSYN	751	753	GCG	70	72	GTA	31;33;33	G;T;A	27;28;28	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	S271T	NONSYN	811	813	TCG	130	132	ACT	48;47;46	A;C;T,G	43;43;41,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	136	138	GAT	36;36;32	G;A;T	34;34;30	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	D276N	NONSYN	826	828	GAT	145	147	AAC	33;33;34	A;A;C	31;31;31	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	N277H	NONSYN	829	831	AAC	148	150	CAC	34;34;34	C;A;C	31;31;31	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	R307E	NONSYN	919	921	AGA	238	240	GAA	12;12;12	G;A;A	12;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	250	252	GCA	12;11;11	G;C;A	12;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	E312D	NONSYN	934	936	GAA	253	255	GAC	11;11;11	G;A;C	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	259	261	ATC	10;11;11	A;T;C	10;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	265	267	TCG	11;10;10	T;C;G	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	271	273	GCC	10;10;10	G;C;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	274	276	AGC	10;10;10	A;G;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	277	279	GCC	10;10;10	G;C;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	347	23.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	283	285	GTT	10;11;11	G;T;T	10;11;11	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	155	3004	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1491	199.8	1	SNP	p	G120K	1	.	.	358	360	AAG	685	687	AAG	247;246;247	A;A;G,C	229;233;226,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	155	3004	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1491	199.8	1	SNP	p	A121N	1	.	.	361	363	AAC	688	690	AAC	248;248;249	A;A;C	232;232;229	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	155	3004	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1491	199.8	1	SNP	p	N121D	0	.	.	361	363	AAC	688	690	AAC	248;248;249	A;A;C	232;232;229	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	155	3004	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1491	199.8	0	HET	.	.	.	G634A	.	634	634	G	961	961	G	231	G,A	146,70	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10720	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5051	211.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1088	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1182	91.8	1	SNP	p	V57M	1	.	.	169	171	ATG	582	584	ATG	219;215;216	A;T;G	208;203;204	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
